Srinivasan Shreya, Balakumaran C, Sukanya G, Kumar N Ashok, Megalai A Sakthi, Senthilvel Aswin
Department of Dermatology, Venereology and Leprosy, Sree Balaji Medical College and Hospital, Chromepet, Chennai, Tamil Nadu, India.
Indian Dermatol Online J. 2025 Apr 17;16(3):414-419. doi: 10.4103/idoj.idoj_506_24. eCollection 2025 May-Jun.
Acanthosis nigricans (AN) presents a significant challenge for dermatologists, as it is a common condition yet often proves resistant to treatment.
To compare the effects of 0.025% topical tretinoin, 4% retinol peel, and 10% retinol peel, in the management of AN of neck using Acanthosis Nigricans Area Severity Index (ANASI) score.
Patients with AN of neck were recruited to the study with due consideration to the inclusion criteria and were divided into 3 groups based on the treatment administered which was either 0.025% topical tretinoin, 4% retinol peel, or 10% retinol peel. The patients were followed-up every 2 weeks up to 8 weeks with ANASI score and Likert scale.
All the groups demonstrated statistically significant improvement but participants in the topical group achieved a slightly better reduction, with a mean ANASI score of 10 at final follow-up, followed by 10% retinol and 4% retinol peel with a mean ANASI score of 12 and 11, respectively. Overall, though 4% retinol peel group had the least reported side effects, patient satisfaction score was found to be higher among the participants in the topical group.
Small sample size and allocation of patients to different treatment groups was not randomized.
Among the three groups, topical tretinoin group showed better response when compared to 4% and 10% retinol peels and, as such, can be a preferred mode of treatment since it is also cost effective over the more expensive chemical peels. Thus, in the era of chemical peels and lasers, topical treatment with retinoids still holds good.
黑棘皮病(AN)给皮肤科医生带来了重大挑战,因为它是一种常见病症,但往往对治疗有抗性。
使用黑棘皮病面积严重程度指数(ANASI)评分,比较0.025%外用维甲酸、4%视黄醇焕肤和10%视黄醇焕肤对颈部AN的治疗效果。
根据纳入标准招募颈部AN患者,并根据所接受的治疗分为3组,治疗分别为0.025%外用维甲酸、4%视黄醇焕肤或10%视黄醇焕肤。每2周对患者进行随访,直至8周,采用ANASI评分和李克特量表。
所有组均显示出统计学上的显著改善,但外用组参与者的改善略好,最终随访时平均ANASI评分为10,其次是10%视黄醇组和4%视黄醇焕肤组,平均ANASI评分分别为12和11。总体而言,虽然4%视黄醇焕肤组报告的副作用最少,但外用组参与者的患者满意度得分更高。
样本量小,且患者分配到不同治疗组未随机化。
在这三组中,与4%和10%视黄醇焕肤相比,外用维甲酸组显示出更好的反应,因此,它可以作为一种首选的治疗方式,因为与更昂贵的化学焕肤相比,它也具有成本效益。因此,在化学焕肤和激光时代,维甲酸类药物的局部治疗仍然有效。